Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arielle Elkrief, MD
CHUM
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- London Health Sciences Centre
London, Ontario, Canada
- Drcc Lakeridge Health
Oshawa, Ontario, Canada
- Sunnybrook Health Sciences Centre/sunnybrook Research Institute
Toronto, Ontario, Canada
- Centre Hospitalier de L'Université de Montréal (chum)
Montreal, Quebec, Canada
- Mcgill University Health Center
Montreal, Quebec, Canada
- Chu de Québec, Centre Intégré En Cancérologie (cic), Hôpital de L'Enfant-Jésus
Québec, Quebec, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Nov 2021
- Primary completion
- 1 Sept 2024
- Completion
- 1 Sept 2025
- Last update posted
- 7 Aug 2024
- Registered enrollment
- 45
- Registry id
- NCT04951583
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.